FAQ

KAI 9803

Known as: KAI-9803, KAI9803 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2007-2011
01220072011

Related topics

Related topics

2 relations

Broader (1)

Peptides

Narrower (1)

delcasertib

Related mentions per year

Related mentions per year

1936-2018
19401960198020002020
KAI 9803
Peptides
delcasertib

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
Distribution of KAI-9803, a novel δ-protein kinase C inhibitor, after intravenous administration to rats.
KAI-9803 is composed of a selective δ-protein kinase C (δPKC) inhibitor peptide derived from the δV1-1 portion of δPKC (termed… (More)
Is this relevant?
2011
2011
Approach to evaluating dried blood spot sample stability during drying process and discovery of a treated card to maintain analyte stability by rapid on-card pH modification.
Unstable drug candidates often lead to complexity for both sample collection and bioanalysis. Dried blood spot (DBS) technology… (More)
Is this relevant?
2008
2008
Intracoronary KAI-9803 as an adjunct to primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction.
BACKGROUND KAI-9803, a delta-protein kinase C inhibitor, has been shown to ameliorate injury associated with ischemia and… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
2008
2008
Letter by Metzler et al regarding article, "Intracoronary KAI-9803 as an adjunct to primary coronary intervention for acute ST-segment elevation myocardial infarction".
“Intracoronary KAI-9803 as an Adjunct to Primary Coronary Intervention for Acute ST-Segment Elevation Myocardial Infarction” To… (More)
Is this relevant?
2008
2008
Intracoronary KAI-9803 as an Adjunct to Primary Percutaneous Coronary Intervention for Acute ST-Segment Elevation Myocardial Infarction
  • 2008
Background—KAI-9803, a -protein kinase C inhibitor, has been shown to ameliorate injury associated with ischemia and reperfusion… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
2008
2008
Intracoronary KAI-9803 as an Adjunct to Primary Percutaneous Coronary Intervention for Acute ST-Segment Elevation Myocardial Infarction
  • 2008
Background—KAI-9803, a -protein kinase C inhibitor, has been shown to ameliorate injury associated with ischemia and reperfusion… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
2007
2007
Delta Mi
  • sind geplant.
  • Herz Kardiovaskuläre Erkrankungen
  • 2007
KAI-9803 ist ein selektiver kompetitiver Inhibitor der Proteinkinase Cd, welcher an der Entstehung eines Reperfusionsschadens… (More)
Is this relevant?